ANTX earnings: a positive outcome, +6.9%

On May 10, 2022, AN2 Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +6.9% in the window around the event. It had already run +24.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.